Jump to content
Health NZ Taranaki Lab Manual

Tests:Estradiol, Serum: Difference between revisions

Department
Biochemistry
Tests:Estradiol, Serum
No edit summary
No edit summary
 
(3 intermediate revisions by 3 users not shown)
Line 24: Line 24:
|Availability
|Availability
|Monday to Friday
|Monday to Friday
Weekend testing to be arranged
Weekend and public holiday testing by arrangment
|-
|-
|Turnaround Time
|Turnaround Time
Line 30: Line 30:
|-
|-
|Stability – Add test
|Stability – Add test
|
|24 hours unseperated
|-
|-
! colspan="2" |
! colspan="2" |
Line 37: Line 37:
|Specimen  
|Specimen  
|Serum
|Serum
Plasma
|-
|-
|Preferred
|Preferred
|6 mL Plain <span style="background:#e30022"> Red-Top</span>
|<span style="background: #fbec5d">Yellow-Top</span> or <span style="background:#e30022"> Red-Top</span> tube
|-
|-
|Acceptable
|Acceptable
|5mL <span style="background: #fbec5d"> Yellow-Top</span>
|
|-
|-
|Unacceptable
|Unacceptable
Line 53: Line 51:
|-
|-
|Paediatric Requirements
|Paediatric Requirements
|0.5 mL in a <span style="background:#e30022"> Red-Top</span> or <span style="background: #fbec5d"> Yellow-Top</span> tube 
|0.5 mL in a <span style="background:#e30022"> Red-Top</span> microtainer
|-
|-
! colspan="2" |
! colspan="2" |
Line 76: Line 74:
|
|
{| class="wikitable"
{| class="wikitable"
|Female
|Units
|pmol/L
|pmol/L
|-
| colspan="2" |Female :
|-
|-
|Follicular  phase
|Follicular  phase
Line 91: Line 91:
|<103          
|<103          
|-
|-
|Male           
| colspan="2" |
|-
|Male :          
|<160            
|<160            
|}
|}
Line 97: Line 99:
|-
|-
|Test Method
|Test Method
|Abbott Alinity Ci analyser using Abbott immunoassay reagent. 
|Abbott Alinity i series analyser using Abbott reagents.  Chemiluminescent microparticle immunoassay.
|-
|-
|Advanced Notice
|Advanced Notice
Line 108: Line 110:
== Comments ==
== Comments ==
|-
|-
| colspan="2" |Samples from patients receiving oestrogen replacement therapy including Premarin may yield spurious oestradiol results.  
| colspan="2" |Samples from patients receiving oestrogen replacement therapy including Premarin may yield spurious oestradiol results.  


   
   
|}
|}
{{DocMeta
| owner = Crossley1
| review_ping =
}}

Latest revision as of 21:40, 23 September 2026


Overview

Department Biochemistry
Test Code TOES
Synonyms Oestradiol

Estradiol 

E2 

17 beta estradiol

Availability Monday to Friday

Weekend and public holiday testing by arrangment

Turnaround Time 2 hrs – 2 days 
Stability – Add test 24 hours unseperated

Specimen Requirements

Specimen Serum
Preferred Yellow-Top or Red-Top tube
Acceptable
Unacceptable
Specimen Transportation
Paediatric Requirements 0.5 mL in a Red-Top microtainer

Aliquot Requirements

Sample Serum 
Preferred Volume
Minimum Volume 200ul
Aliquot Transportation

Clinical Information

Reference Intervals
Units pmol/L
Female :
Follicular phase 77 - 920  
Mid-cycle 140 - 2380  
Luteal phase       77-1145      
Post menopausal <103          
Male :           <160            
Test Method Abbott Alinity i series analyser using Abbott reagents.  Chemiluminescent microparticle immunoassay.
Advanced Notice
Patient Preparation

Comments

Samples from patients receiving oestrogen replacement therapy including Premarin may yield spurious oestradiol results.

 

Owner Clair Crossley (Crossley1)
Last reviewed 23 Sep 2026
Next review 23 Sep 2027 OK